Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/4116 stock hub

TPEX/4116 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4116is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4116

In the news

Latest news · TPEX/4116

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E25.5

P25 14.4P50 18P75 31.9

ROE9.7

P25 -16.2P50 0.3P75 9.8

ROIC6.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4116 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

TWD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	405
Enterprise value	TWD 4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	TW0004116009
Last refreshed	2026-05-10
Market cap	TWD 1.7B
Price	TWD 39.2
Price currency	TWD
Rev Per Employee	13,211,451.85x
Sector	Healthcare
Sic	3842
Symbol	tpex/4116
Website	https://www.benqmedicaltech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	57.85x
EV/EBIT	11.68x
EV/EBITDA	6.89x
EV/FCF	10.69x
EV/Sales	0.74x
FCF yield	21.21%
P/B ratio	0.78x
P/E ratio	25.52x
P/S ratio	0.33x
PE Ratio10 Y	29.51x
PE Ratio3 Y	22.97x
PE Ratio5 Y	23.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.34%
EBITDA Margin	9.62%
FCF margin	6.92%
Gross margin	32.15%
Gross Profit	TWD 1.7B
Gross Profit Growth	12.29%
Gross Profit Growth Q	7.82%
Gross Profit Growth3 Y	7.79%
Gross Profit Growth5 Y	25.31%
Net Income	TWD 68.5M
Net Income Growth	-34.43%
Net Income Growth Q	-43.6%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-15.93%
Net Income Growth5 Y	3%
Pretax Margin	6.31%
Profit Margin	1.28%
Profit Per Employee	TWD 169,037
Profitable Years	19
ROA	3.89
Roa5y	4.23
ROCE	10.28
ROE	9.68
Roe5y	9.15
ROIC	6.84
Roic5y	8.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.37%
Cagr15y	5.77%
Cagr1y	0.53%
Cagr20y	18.15%
Cagr3y	-12.25%
Cagr5y	6.14%
Div CAGR10	5.16%
Div CAGR3	48.88%
Div CAGR5	4.1%
EPS Growth	-34.07
EPS Growth Q	-43.6
EPS Growth Years	0
EPS Growth3 Y	-15.77
EPS Growth5 Y	3.07
FCF Growth3 Y	1.02%
FCF Growth5 Y	28.66%
OCF Growth	195.49%
OCF Growth10 Y	22.13%
OCF Growth3 Y	-4.11%
OCF Growth5 Y	22.98%
Revenue Growth	8.35x
Revenue Growth Q	7.87x
Revenue Growth Quarters	23x
Revenue Growth Years	9x
Revenue Growth3 Y	3.57x
Revenue Growth5 Y	30.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.98
Assets	TWD 5.6B
Cash	TWD 886.9M
Current Assets	TWD 3.6B
Current Liabilities	TWD 2.3B
Debt	TWD 1.9B
Debt EBITDA	TWD 3.31
Debt Equity	TWD 0.85
Debt FCF	TWD 5.14
Equity	TWD 2.2B
Interest Coverage	7.53
Liabilities	TWD 3.3B
Long Term Assets	TWD 1.9B
Long Term Liabilities	TWD 1.1B
Net Cash	TWD -1B
Net Cash By Market Cap	TWD -58.29
Net Debt EBITDA	TWD 1.98
Net Debt Equity	TWD 0.45
Net Debt FCF	TWD 2.75
Tangible Book Value	TWD 622.8M
Tangible Book Value Per Share	TWD 13.98
WACC	3.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Inventory Turnover	4.01
Net Working Capital	TWD 1.4B
Quick ratio	0.83
Working Capital	TWD 1.4B
Working Capital Turnover	TWD 4.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.59%
Dividend Growth	-17.5%
Dividend Growth Years	0%
Dividend per share	TWD 2
Dividend Years	18
Dividend Yield	5.1%
Ex Div Date	2025-06-30
Last Dividend	TWD 1.65
Payout Frequency	Annual
Payout Ratio	107.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	14.53%
1Y total return	0.52%
200-day SMA	43.52
3Y total return	-32.44%
50-day SMA	40.11
50-day SMA vs 200-day SMA	50under200
5Y total return	34.68%
All Time High	160
All Time High Change	-75.5%
All Time High Date	2015-12-01
All Time Low	1
All Time Low Change	3,820%
All Time Low Date	2008-10-28
ATR	0.72
Beta	0.39
Beta1y	0.11
Beta2y	0.38
Ch YTD	-11.11
High	39.45
High52	53.3
High52 Date	2025-09-02
High52ch	-26.45%
Low	39.15
Low52	38.6
Low52 Date	2026-04-27
Low52ch	1.55%
Ma50ch	-2.26%
Price vs 200-day SMA	-9.92%
RSI	40.39
RSI Monthly	37.65
RSI Weekly	36.31
Sharpe ratio	-0.01x
Sortino ratio	0.29
Total Return	5.69%
Tr YTD	-11.11
Tr15y	132.02%
Tr1m	-0.51%
Tr1w	-2%
Tr3m	-7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 339M
Operating Income Growth	-2.01
Operating Income Growth Q	-4.64
Operating Income Growth3 Y	-5.43
Operating Income Growth5 Y	29.42
Operating margin	6.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,050,061%
Net Borrowing	127,572,000
Shares Insiders	1.38%
Shares Out	44,566,000
Shares Qo Q	-0.77%
Shares Yo Y	-0.59%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 370.5M
Average Volume	34,859.3x
Bv Per Share	23.5
CAPEX	TWD -64.2M
Ch10y	-14.78
Ch15y	50.77
Ch1m	-0.51
Ch1w	-2
Ch1y	-3.45
Ch20y	646.7
Ch3m	-7
Ch3y	-39.51
Ch5y	16.32
Ch6m	-16.42
Change	-0.63%
Change From Open	-0.63
Close	39.45
Days Gap	0
Depreciation Amortization	175,480,000
Dollar Volume	1,463,375.2
Earnings Date	2026-08-06
EBIT	TWD 339M
EBITDA	TWD 514.5M
EPS	TWD 1.54
F Score	6
FCF	TWD 370.5M
FCF EV Yield	9.35x
FCF Per Share	TWD 8.31
Financing CF	-120,314,000
Fiscal Year End	December
Founded	1,989
Graham Number	28.50068
Graham Upside	-27.29
Income Tax	TWD 119.9M
Investing CF	-279,960,000
Is Primary Listing	1
Last Earnings Date	2025-11-02
Last Report Date	2026-03-31
Last Split Date	2008-09-17
Last Split Type	Reverse
Lynch Fair Value	TWD 7.68
Lynch Upside	-80.41
Ma150	43.73
Ma150ch	-10.36%
Ma20	39.99
Ma20ch	-1.98%
Net CF	32,257,000
Next Earnings Date	2026-08-06
Open	39.45
P FCF Ratio	4.72
P OCF Ratio	4.02
Payment Date	2025-07-28
Position In Range	16.67
Ppne	707,611,000
Price Date	2026-05-08
Price EBITDA	TWD 3.4
Ptbv Ratio	2.8
Relative Volume	1.07x
Revenue	5,350,638,000x
Tax By Revenue	2.24x
Tax Rate	35.51%
Tr20y	2,711.59%
Tr6m	-16.42%
Volume	37,331

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4116 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.1%

$2.00 annual per share

Payout ratio

+107.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.1%

0 consecutive years of growth

Total shareholder yield

+5.7%

Next ex-dividend date: 2025-06-30

Performance

TPEX/4116 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4116?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

TPEX/4116 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.4

Neutral momentum band

Price vs 200-day MA

-9.9%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4116

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4116 stock rating?

tpex/4116 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4116 analysis?

The full report lives at /stocks/tpex/4116/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4116?

The latest report frames tpex/4116 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4116 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.